drugset / Trial / NCT00011973

Chemotherapy in Treating Patients With Advanced Kidney Cancer

NCT00011973

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of fenretinide in treating patients who have advanced kidney cancer.

Timeline

Start
2000-12
Primary completion
2005-10
Completion
2005-10

Drugs

EvaluationDrugModalityDoseRoute
Subject fenretinide Small molecule 900 mg/m2 Oral

Indications